Immediate Impact
1 from Science/Nature 29 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
2024 Standout
Works of Harald Zeuner being referenced
A phase Ib study of the safety and efficacy of atezolizumab (atezo) + bevacizumab (bev) + cobimetinib (cobi) in patients (pts) with metastatic colorectal cancer (mCRC)
2019
IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a SUBSET OF PATIENTS IN THE RANDOMISED GALLIUM TRIAL WITH PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA (MZL)
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Harald Zeuner | 32 | 95 | 61 | 49 | 11 | 137 | |
| Elisa Cupelli | 14 | 52 | 68 | 23 | 9 | 137 | |
| Pingyong Yi | 20 | 74 | 71 | 35 | 14 | 147 | |
| Luca Paruzzo | 30 | 83 | 50 | 40 | 11 | 165 | |
| Muhammed B. Sabdia | 8 | 94 | 64 | 52 | 17 | 140 | |
| Luis Veloza | 7 | 91 | 100 | 27 | 14 | 159 | |
| Jesús Alarcón | 50 | 100 | 115 | 15 | 12 | 188 | |
| Cynthia A. Lynch | 69 | 133 | 21 | 32 | 10 | 224 | |
| Alice Tison | 43 | 99 | 33 | 45 | 15 | 192 | |
| Barbara Mantoan | 28 | 71 | 103 | 11 | 13 | 152 | |
| Surita Dalal | 69 | 48 | 54 | 25 | 11 | 180 |
All Works
Loading papers...